Latency and outcome of prophylaxis in bipolar disorder: role of severity as a confounding variable?
Sharma
Parveen
P
Basu
Debasish
D
Thapar
Satish
S
D018692:Antimanic Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000517:prevention & control; D002220:Carbamazepine / Q000627:therapeutic use*; D015986:Confounding Factors, Epidemiologic; D005260:Female; D006801:Humans; D007902:Length of Stay; D018021:Lithium Chloride / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index; D013997:Time Factors
D018692:Antimanic Agents; D002220:Carbamazepine; D018021:Lithium Chloride